Please join us in the Boston office of Foley & Lardner LLP, together with the Hellenic Innovation Network, on Wednesday, May 4 @ 5:30 p.m. ET for an exciting in-person event, “Frontiers in Life Sciences, the Greek Connection.” The program will include a Fireside Chat with Michel Vounatsos, CEO of Biogen and Nicholas Galakatos, Global Head of Life Sciences at Blackstone, and will be moderated by Anna Protopapas, CEO of Mersana Therapeutics.
Following the discussion, Greek entrepreneurs will pitch their startups, which are fundraising for US expansion.
A cocktail networking reception will follow.
Event Agenda:
- 5:30-6:00 – Networking Reception
- 6:00-7:15 – Fireside Chat, Pitches, Achievement Awards
- 7:15 – 8:30 – Cocktail Networking Reception
To view the invitation and RSVP, please click here.
People
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.